molecular-pathway Downloads
1 downloads found
Despite such a small market, Novartis developed Ilaris (canakinumab), which is now approved in more than 45 countries, including the US, EU and Switzerland.In pursuit of this therapy, Novartis scientists discovered that Muckle-Wells syndrome may share a common molecular pathway associated with other more common conditions. Institutes dedicated to researching ...